Survival analysis of HER2 receptor negative and HER2 receptor low breast cancer patients at a Philippine hospital

被引：0
|
作者：
Arenos, C. C. [1 ]
San Juan, M. [1 ]
Lim, S. [1 ]
Lominoque, A. [1 ]
Reveldez, I. [1 ]
Sison-DImaano, A. [1 ]
Pangandaman, N. [1 ]
Tatoy, V. [1 ]
Uy, T. [1 ]
机构：
[1] Univ Philippines, Div Med Oncol, Dept Med, Philippine Gen Hosp, Manila, Philippines
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.07.460
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P85-2
引用
收藏
页码：S1390 / S1390
页数：1
相关论文
共 50 条
  • [31] Prognostic difference between early breast cancer patients with HER2 low and HER2 zero status
    Cha, Chihwan David
    Kim, Kyung Eun
    Kim, Jungbin
    Um, Eunhae
    Choi, Nayeon
    Lee, Jungsun
    Gwak, Geumhee
    Kim, Jae Il
    Chung, Min Sung
    NPJ BREAST CANCER, 2025, 11 (01)
  • [32] Prognostic significance and evolution of HER2 zero, HER2 low and HER2 positive in breast cancer after neoadjuvant treatment
    Wei, T.
    Wang, D.
    Peng, Y.
    ANNALS OF ONCOLOGY, 2023, 34 : S301 - S302
  • [33] COMPARISON OF HER2 mRNA PCR LEVELS AND IMMUNOHISTOCHEMISTRY (IHC) IN HORMONE RECEPTOR POSITIVE (HR+)/HER2 NEGATIVE (HER2-) EARLY BREAST CANCER
    Tejerina-Peces, Julia
    Amann-Arevalo, Marta
    Ballestin, Pablo
    Gonzalez-Diez, Beatriz
    Paz-Cabezas, Mateo
    Pascual, Alejandro
    de Luna, Alicia
    Garcia-Barberan, Vanesa
    Lopez de Sa, Alfonso
    Garcia-Saenz, Jose Angel
    Moreno, Fernando
    CANCER RESEARCH, 2024, 84 (09)
  • [34] HER2 Mutation Status in Japanese HER2-negative Breast Cancer Patients
    Endo, Yumi
    Dong, Yu
    Yoshimoto, Nobuyasu
    Asano, Tomoko
    Hato, Yukari
    Yamashita, Hiroko
    Sato, Shinya
    Takahashi, Satoru
    Fujii, Yoshitaka
    Toyama, Tatsuya
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (07) : 619 - 623
  • [35] Survival outcome of weak estrogen/progesterone receptor expression in Her2 negative breast cancer is similar to triple negative breast cancer
    Liao, G-S.
    Hsu, H-M.
    Chu, C-H.
    Hong, Z-J.
    Fu, C-Y
    Chou, Y-C
    Huang, T-C.
    Dai, M-S
    Yu, J-C.
    ANNALS OF ONCOLOGY, 2015, 26 : 20 - 20
  • [36] Survival outcome of weak estrogen/progesterone receptor expression in HER2 negative breast cancer is similar to triple negative breast cancer
    Liao, G. -S.
    Dai, M. -S.
    Hsu, H. -M.
    Chu, C. -H.
    Hong, Z. -J.
    Fu, C. -Y.
    Chou, Y. -C.
    Huang, T. -C.
    Yu, J. -C.
    EJSO, 2017, 43 (10): : 1855 - 1861
  • [37] The association of HER2 low expression with the efficacy of CDK4/6 inhibitor in hormone receptor positive HER2 negative metastatic breast cancer.
    Bao, Kelvin K. H.
    Sutanto, Leone
    Tse, Shirley S. W.
    Cheung, Ka Man
    Chan, Jeffrey C. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [38] Prognostic value of the progesterone receptor by proliferation rate in patients with luminal HER2 negative breast cancer
    Van Asten, Kathleen
    Van Calster, Ben
    Lintermans, Anneleen
    Brouckaert, Olivier
    Floris, Giuseppe
    Wildiers, Hans
    Neven, Patrick
    CANCER RESEARCH, 2015, 75
  • [39] Characterization of the tumor microenvironment in patients with hormone receptor positive, HER2 negative early breast cancer
    Kearney, Matthew Ryan
    Vanguri, Rami
    Wang, Qi
    Fenn, Kathleen
    Guo, Hua
    Marks, Douglas
    Hibshoosh, Hanina
    Kalinsky, Kevin M.
    Connolly, Eileen
    CANCER RESEARCH, 2022, 82 (04)
  • [40] False-negative results of hyperexpression of HER2 receptor in breast cancer at a public tertiary hospital in Brazil
    Batista, Bruno
    Ioshii, Sergio
    Padilha, Sergio
    Nabhen, Jacqueline
    Ostroski, Tayza
    Batista, Caroline
    CANCER RESEARCH, 2024, 84 (09)
12345